HTx
Predicting HEart Transplantation outcomes
transplantation medicine
ill heart failure patients
Clinical implementation of uPROPHET findings
personalised medicine
selection of patients
graft performance
graft rejection
major impact
proteomic profiles
graft function
immunosuppression
proof of concept underlying uPROPHET rests
EPLORE findings
Urinary PROteomics
European research
invasive risk
standard approach
major challenges
targeted approach
adverse cardiovascular outcomes
non-invasive stratification of risk
shortage of donor hearts
competitive fields of biomarker research
tissue samples of explanted hearts
renal impairment
signatures
urine
subclinical left ventricular dysfunction
capillary electrophoresis
high-resolution mass-spectroscopy
immune system activity
translation of state-of-the-art technology
disease
greatest probability of survival
innovative services
maximum of high-quality years
unpredictable course
customer
forefront
prognostic tool helpful
plans
inconvenient margin of uncertainty
case
business partner
life
evident benefit
instrument
analogy
Consensus criteria
indications
procedure
Endomyocardial biopsies
classifiers
profiling